We found that EGFR signaling activated IRE1α through EGFR-MEK-ERK pathway, inhibition of MEK or ERK could reduce the IRE1α phosphorylation and XBP1s expression in colorectal cancer cell lines. This evidence concerns the gene EGFR and colorectal cancer.